Literature DB >> 8054718

Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme.

T R Henion1, B A Macher, F Anaraki, U Galili.   

Abstract

The glycosylation enzyme alpha 1,3 galactosyltransferase, which synthesizes the carbohydrate Gal alpha 1-3Gal beta 1-4GlcNAc-R, is active in non-primate mammals, prosimians and New World monkeys, but not in Old World monkeys, apes and humans. In this study, we have cloned and sequenced the enzyme expressed in a New World monkey, determined the exact size of the stem region and assessed the minimal size of catalytically active alpha 1,3 galactosyltransferase (alpha 1,3GT). Various primer sets were used in the polymerase chain reaction to generate cDNAs which coded for forms of alpha 1,3GT with deletions at the N- or C-terminal domains. The cDNA was inserted into the expression vector pPROTA which contains the coding sequence for protein A, and subsequently transfected into COS cells. The soluble chimeric products (truncated enzyme and protein A) were harvested from the cell culture medium using IgG-Sepharose beads and assayed for enzymatic activity. As many as 67 amino acids could be truncated at the amino terminal region of the luminal portion of the enzyme without affecting its catalytic activity. Truncation of 68, 69 and 74 amino acids resulted in a 50, 75 and > 95% loss in the in vitro catalytic actively, respectively. Introduction of a frameshift mutation which is characteristic of apes and human alpha 1,3GT gene resulted in the complete loss of enzyme activity. Moreover, truncation of as few as three amino acids at the carboxyl end of alpha 1,3GT resulted in complete loss of the catalytic activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054718     DOI: 10.1093/glycob/4.2.193

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  15 in total

Review 1.  Organization of Golgi glycosyltransferases in membranes: complexity via complexes.

Authors:  W W Young
Journal:  J Membr Biol       Date:  2004-03-01       Impact factor: 1.843

2.  Profiling terminal N-acetyllactosamines of glycans on mammalian cells by an immuno-enzymatic assay.

Authors:  Haruko Ogawa; Uri Galili
Journal:  Glycoconj J       Date:  2006-11-18       Impact factor: 2.916

3.  Porcine alpha-1,3-galactosyltransferase: full length cDNA cloning, genomic organization, and analysis of splicing variants.

Authors:  A Katayama; H Ogawa; K Kadomatsu; N Kurosawa; T Kobayashi; N Kaneda; K Uchimura; I Yokoyama; T Muramatsu; H Takagi
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

4.  Studies on the conformational behaviour of GlcNAc-Man3-GlcNAc2 oligosaccharides using molecular dynamics simulations.

Authors:  T Kozar; I Tvaroska; J P Carver
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

5.  Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.

Authors:  Ussama Abdel-Motal; Shixia Wang; Shan Lu; Kim Wigglesworth; Uri Galili
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 6.  Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.

Authors:  Uri Galili
Journal:  J Mol Evol       Date:  2014-10-15       Impact factor: 2.395

7.  Functional domains of bovine beta-1,4 galactosyltransferase.

Authors:  E E Boeggeman; P V Balaji; P K Qasba
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

8.  Site-directed mutagenesis of glutamate 317 of bovine alpha-1,3Galactosyltransferase and its effect on enzyme activity: implications for reaction mechanism.

Authors:  Patricia Molina; Ronald M A Knegtel; Bruce A Macher
Journal:  Biochim Biophys Acta       Date:  2007-05-10

9.  Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study.

Authors:  Ying Qiu; Mark M Yun; Ming Bao Xu; Yi Zhong Wang; Sheng Yun
Journal:  Int J Clin Oncol       Date:  2012-07-31       Impact factor: 3.402

10.  Characterization of a metal-independent CAZy family 6 glycosyltransferase from Bacteroides ovatus.

Authors:  Percy Tumbale; Keith Brew
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.